Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United States

被引:8
|
作者
Moon, Rena C. [1 ]
Marijam, Alen [2 ]
Mitrani-Gold, Fanny S. [3 ]
Gibbons, Daniel C. [4 ]
Kartashov, Alex [1 ]
Rosenthal, Ning A. [1 ]
Joshi, Ashish, V [2 ]
机构
[1] Premier Inc, Appl Res, Ping Al Appl Sci, Charlotte, NC USA
[2] GSK, Value Evidence & Outcomes, Collegeville, PA 19426 USA
[3] GSK, Epidemiol, Collegeville, PA USA
[4] GSK, Value Evidence & Outcomes Real World Analyt, Brentford, Middx, England
来源
PLOS ONE | 2022年 / 17卷 / 11期
基金
芬兰科学院;
关键词
D O I
10.1371/journal.pone.0277713
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background We evaluated associations between antibiotic prescription and healthcare resource use and costs (Part A), and between antibiotic switching and healthcare resource use, costs, and uncomplicated urinary tract infection recurrence (Part B) in female patients with uncomplicated urinary tract infection in the United States. Methods This retrospective cohort study of linked Optum and Premier Healthcare Database data included female patients >= 12 years old with an uncomplicated urinary tract infection diagnosis (index date), who were prescribed antibiotics during an outpatient/emergency department visit between January 1, 2013 and December 31, 2018. In Part A, patients were stratified by antibiotic prescription appropriateness: appropriate and optimal (compliant with Infectious Diseases Society of America 2011 guidelines for drug class/treatment duration) versus inappropriate/suboptimal (inappropriate drug class/treatment duration per Infectious Diseases Society of America 2011 guidelines, and/or treatment failure). In Part B, patients were stratified by treatment pattern (antibiotic switch vs no antibiotic switch). Healthcare resource use and costs during index episode (within 28 days of index date) and 12-month follow-up were compared. Results Of 5870 patients (mean age 44.5 years), 2762 (47.1%) had inappropriate/suboptimal prescriptions and 567 (9.7%) switched antibiotic. Inappropriate/suboptimal prescriptions were associated with higher healthcare resource use (mean number of ambulatory care and pharmacy claims [both p < 0.001]), and higher total mean cost (inpatient, outpatient/emergency department, ambulatory visits, and pharmacy costs) per patient ($2616) than appropriate and optimal prescriptions ($649; p < 0.001) (Part A). Antibiotic switching was associated with more pharmacy claims and higher total mean costs (p <= 0.01), and a higher incidence of recurrent uncomplicated urinary tract infection (18.9%) than no antibiotic switching (14.2%; p < 0.001) (Part B). Conclusions Inappropriate/suboptimal prescriptions and antibiotic switching were associated with high costs, ambulatory care, and pharmacy claims, suggesting a need for improved uncomplicated urinary tract infection prescribing practices in the United States.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED STATES
    Cameron, A.
    Barrett, M.
    Malik, A.
    Woodford, C.
    Alpert, N.
    Vuong, V.
    Boers, E.
    Kaye, L.
    Sterling, K. L.
    VALUE IN HEALTH, 2022, 25 (12) : S176 - S176
  • [32] Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK
    Guest, JF
    Ruiz, FJ
    Greener, MJ
    Trotman, IF
    EUROPEAN JOURNAL OF CANCER CARE, 2006, 15 (01) : 65 - 73
  • [33] Racial disparities in treatment patterns, healthcare resource use, and outcomes in patients with pulmonary arterial hypertension in the United States
    Melendres-Groves, Lana
    Tang, Wenze
    Germack, Hayley D.
    Liu, Zhiwen
    Sadik, Kay
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (09) : 1465 - 1475
  • [34] COMPARISON OF HEALTHCARE RESOURCE USE AND COSTS BETWEEN PATIENTS WITH DIAGNOSED HOMOCYSTINURIA AND PHENYLKETONURIA IN THE UNITED STATES
    Sellos-Moura, M.
    Glavin, J. F.
    Lapidus, D.
    Horn, P. T.
    Evans, K. A.
    Lew, C. R.
    Irwin, D.
    VALUE IN HEALTH, 2019, 22 : S153 - S153
  • [35] THE IMPACT OF HIGH RISK AND CHRONIC OPOID USE AMONG COMMERCIALLY INSURED ENDOMETRIOSIS PATIENTS ON HEALTHCARE RESOURCE USE AND COSTS IN THE UNITED STATES
    Estes, S.
    Soliman, A. M.
    Zivkovic, M.
    Zhu, X.
    Chopra, D.
    VALUE IN HEALTH, 2020, 23 : S239 - S239
  • [36] TREATMENT PATTERNS, HEALTH CARE RESOURCE UTILIZATION AND COSTS IN UNITED STATES PATIENTS DIAGNOSED WITH CHRONIC HEPATITIS C INFECTION
    Le, T. K.
    Kalsekar, A.
    Yuan, Y.
    Macaulay, D.
    Sorg, R. A.
    Behrer, C. R.
    Arunajadai, S. G.
    Wei, J.
    Wu, E. Q.
    VALUE IN HEALTH, 2014, 17 (03) : A40 - A41
  • [37] Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States
    Yang, Xiaoqin
    Laliberte, Francois
    Germain, Guillaume
    Raut, Monika
    Duh, Mei Sheng
    Sen, Shuvayu S.
    Lejeune, Dominique
    Desai, Kaushal
    Armand, Philippe
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 469 - 478
  • [38] FACTORS ASSOCIATED WITH ADVERSE SHORT-TERM HEALTH OUTCOMES AMONG FEMALE OUTPATIENTS WITH UNCOMPLICATED URINARY TRACT INFECTION
    Kaye, Keith S.
    Gupta, Vikas
    Mulgirigama, Aruni
    Trautner, Barbara W.
    Mitrani-Gold, Fanny S.
    Scangarella-Oman, Nicole E.
    Yu, Kalvin
    Ye, Gang
    Joshi, Ashish V.
    JOURNAL OF UROLOGY, 2021, 206 : E458 - E459
  • [39] Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
    Zhang, Dongmu
    Prabhu, Vimalanand S.
    Marcella, Stephen W.
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (09) : 1326 - 1332
  • [40] Healthcare resource utilization and costs among children with cystic fibrosis in the United States
    Thorat, Teja
    McGarry, Lisa J.
    Bonafede, Machaon M.
    Limone, Brendan L.
    Rubin, Jaime L.
    Jariwala-Parikh, Krutika
    Konstan, Michael W.
    PEDIATRIC PULMONOLOGY, 2021, 56 (09) : 2833 - 2844